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Skeletal muscle adapts to different patterns of motor nerve activity
by alterations in gene expression that match specialized properties
of contraction, metabolism, and muscle mass to changing work
demands (muscle plasticity). Calcineurin, a calciumcalmodulin-
dependent, serine–threonine protein phosphatase, has been
shown to control programs of gene expression in skeletal muscles,
as in other cell types, through the transcription factor nuclear
factor of activated T cells (NFAT). This study provides evidence that
the function of NFAT as a transcriptional activator is regulated by
neuromuscular stimulation in muscles of intact animals and that
calcium influx from the transient receptor potential (TRPC3) chan-
nel is an important determinant of NFAT activity. Expression of
TRPC3 channels in skeletal myocytes is up-regulated by neuromus-
cular activity in a calcineurin-dependent manner. These data sug-
gest a mechanism for cellular memory in skeletal muscles whereby
repeated bouts of contractile activity drive progressively greater
remodeling events.
Skeletal muscles consist of a mosaic of multinucleatedmyofibers differing in size, metabolic capacity, mitochon-
drial content, and contractile properties. Determinants of
specialized myofiber phenotypes are programmed during fetal
development but are modulated in response to changing motor
nerve input (1–3). This plasticity allows myofibers to match
cellular capacities to different physiologic demands, as dem-
onstrated in classic cross-innervation and chronic low-
frequency stimulation experiments performed on adult mus-
cles (4, 5). These adaptive responses are minimal after a single
period of neuromuscular activity but become fully manifest
only after repeated bouts of activity pursued over a period of
days to weeks, as exemplified by the results of training in
human athletes. Thus, the physiologically important phenom-
enon of muscle plasticity, familiar to muscle physiologists for
decades (6, 7), includes a form of cellular memory, the
molecular basis of which has been poorly understood.
We have reported that calcineurin, a serine–threonine
phosphatase, functions as an effector for calcium-dependent
signaling pathways in skeletal myofibers by inducing a program
of gene expression associated with slow oxidative myofibers (8,
9). Calcineurin activates the transcription factors nuclear
factor of activated T cells (NFAT) and myocyte enhancer
factor 2, which in turn alter the expression of target genes (5,
9, 10). Constitutively active calcineurin expressed in myofibers
of intact animals activates genes that encode contractile
proteins, ion channels, and myoglobin that establish the slow
oxidative myofiber phenotype (5).
How are changes in intracellular calcium associated with
differing patterns of excitation–contraction coupling inter-
preted by calcineurinNFAT to alter gene transcription? The
present study used a transgenic mouse model to assess the
functional state of NFAT proteins in the skeletal muscle of
intact animals. In addition, we assessed the relative contribu-
tions of different intracellular pools of calcium to the control
of NFAT function in cultured myocytes. These studies reveal
a role for non-voltage-dependent calcium inf lux from the
extracellular space in controlling the subcellular compartmen-
talization and transactivator function of NFAT. In particular,
expression of TRPC3, a nonselective calcium inf lux channel, is
increased in response to neurostimulation and activated cal-
cineurin and is limiting to NFAT-dependent transactivation.
We propose that TRPC3 channels participate in a positive
feedback circuit, thereby conferring a form of cellular memory
that is a prominent feature of adaptive plasticity of skeletal
muscles in response to neurostimulation.
Methods
Construction of NRE-lacZ Reporter. The NFAT binding sites,
f lanked by HindIII restriction enzyme sites, were amplified by
PCR by using the pNFAT plasmid (Stratagene). The construct
used in this study contained four multimerized NFATAP-1
binding domains. The PCR product was ligated and cloned into
the HindIII sites of the vector hsp68-lacZ (11).
Transgenic Mice. Transgenic mice were generated as previously
described (5, 12). Genotyping was determined by Southern
blotting as previously described, with a probe specific to the lacZ
sequence. Of 16 founder animals examined, four independent
lines carrying the reporter gene were established. Data pre-
sented here are from three transgenic lines representing differ-
ent chromosomal insertion sites. All experiments with animals
were reviewed and approved by the Institutional Animal Care
and Research Advisory Committee.
Morphologic and Histologic Analysis. Dissected muscle were fixed
in 2% paraformaldehyde and 0.2% glutaraldehyde in PBS on ice
for 30 min and then stained histochemically for -galactosidase
as described in ref. 5.
Protein Lysates and Immunoblotting. Muscle protein homogenates
were made as described (5). Individual skeletal muscles were
dissected from each mouse and homogenized in a buffer con-
taining PBS, 20% glycerol, 0.1% Triton X-100, 1 mM DTT, and
protease inhibitors. Protein extracts were separated by using
10% SDSPAGE and transferred to a membrane. Immunoblot-
ting was performed with specific antibodies to galactosidase
(1:1,000) from Promega, TRPC3 (1:2,000) from Alamone
(Jerusalem), and ryanodine receptor (RYR), NFATc1, and
tubulin (1:1,000) from Affinity Bioreagents (Golden, CO).
Cell Fractionation and NuclearCytosolic Isolation. After stimulation
with agonists, cells were washed twice in PBS and collected in
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lysis buffer (20 mM Hepes, pH 7.410 mM NaCl1.5 mM
MgCl220% glycerol0.1% Triton X-1001 mM DTTprotease
inhibitors). Cell suspensions were centrifuged at 600  g at 4°C
for 1 min. Supernatants represented the cytosolic fraction, while
pellets (nuclear fraction) were resuspended in lysis buffer sup-
plemented with 500 mM NaCl and rotated for 1 h. The nuclear
fraction was then centrifuged at 16,000  g for 10 min at 4°C.
Cytoplasmic and nuclear proteins were then analyzed by SDS
PAGE and immunoblotted to detect NFATc1 proteins with the
monoclonal specific antibodies from Affinity Bioreagents. To
quantify the NFAT translocation, immunoblots were imaged and
densitometry was determined for individual bands, and results
were expressed as fold translocation over basal state.
Voluntary Wheel Running and Chronic Low-Frequency Neurostimula-
tion. Animals were maintained on a 12:12-h light and dark cycle,
and running activity was monitored by the Dataquest Data
Acquisition System (Data Sciences International, Arden Hills,
MN). For chronic low-frequency stimulation, neurostimulators
were implanted as previously described and attached to the
sciatic nerve of one hind limb. Animals were treated with
cyclosporin A (25 mgkg) or vehicle for 3 days before pacing. For
analysis of TRPC3 transcripts using semiquantitative PCR,
animals were paced for 2 h, and plantaris muscles were harvested
in Triazol to make cDNA. TRPC3 was amplified by using
primers specified in ref. 5. TRPC3 transcripts from six animals
(chronic low-frequency stimulation) were compared to six sham-
operated animals. Data (mean  SE) are expressed as the
induction of TRPC3 relative to cyclophilin expression (TRPC3
intensitycyclophilin intensity).
Cell Culture. C2C12 cells were grown in DMEM supplemented
with 20% FBS, 100 IUml penicillin, and 100 gml strepto-
mycin. Cell differentiation into myotubes took place over 5 days
while cultured in differentiating media (DM) containing DMEM
containing 2% horse serum, 100 IUml penicillin, 100 gml
streptomycin, 10 gml transferrin, 10 gml regular insulin,
and 50 mM Hepes buffer. Experiments involving C2C12 cells
were performed after 5 days in DM. For Ca2 measurement
experiments, cells were plated on gelatin-coated glass coverslips
and switched to DM for 5 days.
Ca2 Imaging. Cells were grown on a glass coverslips and differ-
entiated over 5 days. Cells were then loaded with 10 M fura
2-acetoxymethyl ester for 60 min. The coverslips with fura
2-acetoxymethyl ester-loaded cells attached to them were as-
sembled into the perfusion chamber and continuously perfused
at a rate of 10 mlmin with a constant chamber volume of 200
l. Application of agonists was made by inclusion in the per-
fusate. Loaded cells were illuminated by alternating 350380 nm
light delivered every 1–2 seconds, and fluorescence images were
captured at an emission of 510 nm with a Delta-Scan fluoro-
metric system. Ca2 levels were derived from the change in ratio
of fluorescence intensity at 340 and 380 nm as detailed in ref. 13.
Cloning of the TRPC3 Promoter. PCR primers were designed to
amplify genomic sequences corresponding to the 1,800 bases
upstream of the transcription start site for TRPC3. This PCR
product was subcloned into PGL3-Luciferase obtained from
Promega using the Xba restriction site.
Cell Transfection and Luciferase Assay. C2C12 myoblasts were
plated at 105 cells per well of a six-well dish at least 12 h before
transfection. Cells were transfected with 1.6 g of NRE reporter
or TRPC3 promoter along with CMV-LacZ constructs by using
Lipofectamine 2000 (GIBCOBRL). Cells were differentiated
for 3 days in 2% horse serum and then assayed for luciferase and
-galactosidase from whole-cell extracts as described in ref. 5.
Results
Transactivator Function of NFAT Proteins in Adult Skeletal Muscles.
Transgenic mice were engineered to carry a lacZ reporter gene
under the control of a three copies of a high-affinity NFAT
binding sequence linked to a basal promoter (see Methods).
Results were similar in each of three independent lines of mice
representing different chromosomal insertion sites for the trans-
gene. Expression of the NFAT-dependent lacZ transgene during
embryonic and fetal life was consistent with known sites of
NFAT-regulated developmental events (data not shown). Skel-
etal muscles of adult mice housed under standard conditions
(sedentary) exhibited no detectable expression of lacZ, but the
NFAT-dependent transgene was activated by expression of a
constitutively active form of calcineurin, introduced either by an
adenoviral vector or by genetic crosses of NFAT-lacZ mice to
MCK-CnA animals (5, 14) (Fig. 1A). Likewise, NFAT-
dependent transcription was induced in muscles of intact animals
by neuromuscular activity, generated either by 18–24 h of direct
electrical pacing (10 Hz) of the motor nerve (Fig. 1B) or by daily
bouts of spontaneous wheel running for a 1-week period (Fig.
1C). This response to chronic low-frequency motor nerve stim-
ulation was inhibited in animals that were pretreated with the
calcineurin inhibitor cyclosporin A (25 mgkg per day for 3 days)
as compared with vehicle-treated animals (Fig. 1B). The re-
sponse to running was limited to muscle groups (soleus, gas-
trocnemius) that power this form of locomotor activity (Fig. 1C)
and were not observed in other hind limb muscles [extensor
digitorum longus (EDL)] that are not recruited for this form of
exercise. Induction of LacZ protein from the soleus and plantaris
muscles in response to altered motor nerve activity (running or
motor nerve stimulation) increased in a linear fashion, indicating
a progressive training response.
Extracellular Calcium Sustains NFAT in the Nucleus of Myotubes.
C2C12 cells assemble components of two calcium signaling
pathways including voltage-operated channels involved in exci-
tation–contraction coupling (RYR and dihydropyridine recep-
tor) and non-voltage-dependent calcium channels (IP3R and
TRPC3) that are not required for muscle contraction but serve
other signaling functions. The RYR Ca2 pool contributes Ca2
sufficient to initiate NFATc1 translocation to the nucleus, as was
evident by stimulating myotubes with KCl in the absence of
external Ca2. However, with longer incubations of 10 min in a
Ca2-free bath, NFATc1 was depleted from the nuclear fraction,
suggesting that Ca2 influx from the extracellular space sustains
NFATc1 in the nucleus (Fig. 2A). The specificity of the RYR
pool for initiating NFATc1 translocation was supported by
additional experiments with RYR activators (caffeine) and
inhibitors (ruthenium red) (data not shown). When extracellular
calcium is available, NFATc1 translocates and remains in the
nucleus after cellular depolarization with KCl.
To further characterize the calcium influx required to main-
tain NFATc1 in the nucleus, myotubes were stimulated with
cyclopiazoic acid, an inhibitor of the sarcoplasmic reticulum
sarco(endo)plasmic reticulum Ca2ATPase, in the presence and
absence of external calcium. Used in this fashion, cyclopiazoic
acid (CPA) activates non-voltage-dependent calcium influx (15).
Even small calcium transients evoked by adding calcium to the
media in the presence of CPA were sufficient to maintain
NFATc1 translocation as efficiently as with KCl (Fig. 2B). Thus,
activation of non-voltage-dependent calcium influx provides a
signal sufficient to maintain NFATc1 in the nucleus of myotubes.
The finding that discharge of distinct Ca2 pools regulates
specific steps in NFATc1 translocation into the nucleus raised
the possibility of cooperation between Ca2 pools. Myotubes
were stimulated with caffeine for 1 min to rapidly shuttle
NFATc1 proteins to the nuclear fraction. NFATc1 proteins were
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depleted from the nuclear fraction within 9 min after removal of
caffeine. Activation of Ca2 entry by UTP, a purinergic agonist,
was insufficient in itself to maintain NFATc1 proteins in the
nuclear fraction of myotubes, but it sustained NFATc1 in nuclei
of myotubes conditioned by a 1-min pulse of caffeine (Fig. 2C).
Removal of Ca2out during the stimulation with UTP depleted
the NFATc1 proteins from the nuclear fraction (data not
shown). These data suggest that enhanced Ca2 influx through
non-voltage-dependent calcium channels maintains NFATc1 in
the nucleus.
Increased TRPC3 Channel Expression by Neurostimulation and Cal-
cineurin. TRPC channels encompass a family of nonselective
calcium-inf lux channels that were first described in photo-
transduction in the Drosophila eye (16, 17). A role for TRPC
channels in excitable cells has only recently been suggested
(18–20). Here, we analyzed the expression of TRPC3 in
skeletal muscles from adult mice. As assessed by immunoblot-
ting experiments, TRPC3 expression is greater in muscles
enriched in slow oxidative fibers (soleus) by comparison to
muscles comprising mostly fast glycolytic fibers (EDL) (Fig.
3A). Animals that were provided access to free-wheel running,
a stimulus that promotes mitochondrial biogenesis and myosin
isoform switching (type IIb to IIa) in skeletal muscles (data not
shown), demonstrated up-regulation of TRPC3 expression as
compared with sedentary controls (Fig. 3A). As observed for
NFAT transactivator function, little induction of TRPC3 chan-
nels was seen in EDL muscles that are not recruited during
wheel running. Up-regulation of TRPC3 expression also oc-
curs in fast muscles, as demonstrated by time-dependent
accumulation of the NFAT-regulated transgene product
(LacZ) in plantaris muscles subjected to 2 h of motor nerve
stimulation at 10 Hz (Fig. 3B). TRPC3 expression was also
increased in muscles expressing a constitutively active form of
calcineurin introduced either by adenoviral delivery or by
germ-line transgenesis (Fig. 3C). The effect of calcineurin to
increase the abundance of TRPC3 in skeletal muscles is
mediated, at least in part, by calcineurin-dependent induction
of the TRPC3 gene promoter. An 1800-bp genomic fragment
from the mouse TRPC3 gene was cloned upstream of a
luciferase reporter gene and transfected into C2C12 myogenic
cells. Expression of a constitutively active form of calcineurin
or NFAT increased TRPC3 promoter activity (Fig. 3D). In
contrast, expression of another calcineurin-regulated tran-
scription factor, myocyte enhancer factor 2, failed to activate
the TRPC3 promoter.
Fig. 1. NFAT indicator mice. Hind limb muscles dissected from NRE-LacZ transgenic mice were analyzed by histochemical staining for -galactosidase activity
after stimulation. (A) Expression of constitutively active calcineurin introduced by adenovirus or germ-line transgenesis. (Bar, 40 m in Lower.) (B) Continuous
low-frequency stimulation of the motor nerve at 10 Hz for 18 h in the presence or absence of cyclosporin A. (Bar, 40 m.) (C) Spontaneous wheel running
(sedentary, 3, 7, and 21 days).
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Expression of TRPC3 Channels Modulates Calcium Transients and
Calcium-Regulated NFAT Function in Myocytes. Prolonged calcium
influx was observed in calcium transients evoked by caffeine in
myotubes transfected with a TRPC3 expression plasmid in
comparison with control cells (Fig. 4 Upper). Consistent with
established properties of TRPC3 channels in other cell types,
CPA-induced calcium influx was not enhanced in cells express-
ing TRPC3 (13, 21–23). However, enhanced expression of
TRPC3 channels inf luenced the transactivator function of
NFAT. NFAT-dependent reporter gene activity was increased
2.5-fold in myotubes expressing TRPC3 compared with control
cells, suggesting that increased expression of TRPC3 increased
the regulatory pool of calcium that is pertinent to calcineurin
NFAT signaling (23), even under basal conditions. Prolonged
exposure of cells to caffeine (120 min) induced a 7-fold increase
in NFAT transactivation in myotubes expressing endogenous
levels of TRPC3, but this response was approximately doubled
(to 12-fold) in myotubes with increased expression of TRPC3
channels. Thus, TRPC3 channels control a calcium pool perti-
nent to NFAT transactivation, and the abundance of TRPC3 in
skeletal myocytes is limiting both to the duration of calcium
transients evoked by release of the RYR pool (and the ensuing
Ca2 influx) and to the magnitude of NFAT-dependent tran-
scriptional responses.
Discussion
This study demonstrates that the calcineurin–NFAT signaling
pathway is activated by neuromuscular stimulation in skeletal
muscle of intact animals, and it provides evidence that TRPC3
channels serve as important regulators of this pathway. TRPC
channels are expressed selectively in muscles undergoing sus-
tained or repeated neurostimulation through a calcineurin-
dependent mechanism. These findings provide a plausible ex-
planation for the longstanding observation by physiologists that
single periods of neurostimulation produce only minor and
transient changes in muscle phenotype, while repeated bouts of
contractile activity drive progressively greater and more stable
remodeling events, a phenomenon we characterize as a form of
cellular memory.
Calcineurin regulates the expression of several proteins in-
volved in calcium homeostasis such as ion channels, transporters,
and pumps (24–27). We also have recently shown that compo-
nents of the NFAT–calcineurin pathway including NFATC2,
calcsarcin 1, and latory calcineurin-interacting protein 1 are
differentially expressed in slow oxidative muscles compared with
modulatory fast glycolytic muscles (26). We propose that such
profiles of gene expression represent a form of cellular memory
that is important for maintaining skeletal muscle in the remod-
eled state evoked by changing patterns of neurostimulation.
Fig. 2. Calcium mobilized from different pools and NFAT translocation. Each panel includes calcium transients from fura 2-acetoxymethyl ester-labeled
myotubes, immunoblots of cytoplasmic (C) and nuclear (N) fractions, and histograms presenting mean values (SE) of duplicate determinations from three
independent experiments (*, P 0.01). (A) Release of the RYR pool of intracellular calcium by KCl promotes nuclear translocation of NFAT in C2C12 myotubes.
However, in the absence of extracellular calcium, this response is short-lived and is blocked by ruthenium red, an inhibitor of RYR calcium release (data not
shown). (B) Activation of non-voltage-dependent calcium channels by CPA translocates and sustains NFATc1 in the nucleus in the presence of, but not in the
absence of, extracellular calcium. (C) Release of the RYR pool of calcium by a brief (1-min) exposure of cells to caffeine, followed by activation of
non-voltage-dependent calcium channels with UTP, results in sustained maintenance of NFAT in the nuclear compartment.
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Studies of muscle plasticity going back over several decades (6,
7) show that the time course of responses evoked by neuromus-
cular stimulation requires days or weeks of sustained or repeated
neuromuscular activity for conversion of fast glycolytic myofi-
bers to the slow oxidative phenotype. Likewise, reversion of slow
oxidative fibers back to the fast glycolytic phenotype when motor
nerve input is reduced requires several weeks. The present report
shows how activation of the calcineurin–NFAT pathway alters
expression of important components of the signaling pathway
itself, augmenting the gain to subsequent neurostimulation and
stabilizing the slow oxidative phenotype.
The present results also reveal features of calcium metab-
olism in muscle cells that discriminate, at least in part, pools
of calcium required for muscle contraction from those re-
quired to drive calcium-regulated gene expression. Calcium
released from RYR channels is sufficient to trigger actin–
myosin cross-bridge cycling and muscle contraction without
any requirement for calcium entry from the extracellular space
(28). In contrast, the RYR pool of calcium is insufficient to
maintain NFAT translocation to the nuclear compartment,
and extracellular calcium entering through non-voltage-
dependent Ca2 channels, putatively represented by TRPC3,
is required for NFAT-dependent transactivator function in
skeletal myocytes. This model proposes that sustained con-
tractile activity depletes sarcoplasmic reticulum calcium stores
and opens TRPC channels in a manner capable of enhancing
NFAT-dependent transactivation (Fig. 5).
Fig. 5. Schematic model of the role of TRPC3 in calcium-dependent gene
regulation in skeletal muscle. TRPC3 is expressed in greater amounts in myo-
fibers after neuromuscular activity, a response mediated by the calcineurin–
NFAT pathway. Increased expression of TRPC3 enhances calcineurin–NFAT
signaling that results for subsequent periods of neuromuscular activity,
thereby conferring cellular memory that stabilizes the slow oxidative
phenotype.
Fig. 3. TRPC3 expression in skeletal muscles. TRPC3 expression is increased by
slow oxidative [soleus (Sol)] compared with fast glycolytic (EDL) muscles, and
by spontaneous wheel running for durations of 1 or 3 weeks (A), by chronic
low-frequency neurostimulation at 10 Hz (S, n 6) compared with control (C,
n6) plantaris muscles (mean SE; *, P0.05) (B), and by constitutively active
calcineurin introduced by adenovirus or germ-line transgenesis (C). (D) Tran-
scriptional activity of the TRPC3 promoter (1800-bp genomic fragment linked
to a luciferase reporter gene) is induced by constitutively active NFAT or
calcineurin in C2C12 myogenic cells. *, P  0.003.
Fig. 4. TRPC3 expression is limiting to sustained calcium influx and NFAT
transactivation in C2C12 myotubes. (Upper) Calcium transients in cells stimu-
lated with 15 mM caffeine and expressing a CMV-TPRC3 construct or a control
vector. Each trace represents the mean value of 5–10 cells from one experi-
ment; similar results were obtained in two additional experiments. (Lower)
NFAT-dependent reporter gene expression stimulated by caffeine in myocytes
expressing a CMV-TPRC3 construct or a control vector. Data are corrected for
variations in transfection efficiency by normalization of data to expression of
a cotransfected pCMV-LacZ construct. *, P  0.004.
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Capacitative calcium entry and TRPC channel function have
been found to be dysfunctional in mouse models of muscular
dystrophy caused by mutations in dystrophin or mg29 (18, 20).
In these studies no defects were found in excitation–contraction
coupling. Interestingly, slow oxidative fibers are relatively spared
from injury in muscular dystrophy (29), suggesting that increased
expression of TRPC channels in slow oxidative fibers relative to
fast glycolytic fibers perhaps has protective consequences. In
support of a causal relationship among calcineurin–NFAT sig-
naling, non-voltage-dependent Ca2 channel function, and the
pathobiology of muscular dystrophies, a series of patients with
naturally occurring defects in non-voltage-dependent Ca2 in-
f lux exhibited both impaired NFAT trafficking in lymphocytes
and skeletal myopathy (30). These findings from human subjects
are consistent with our proposal that TRPC3 channels are
important to the processes that match contractile and metabolic
properties of skeletal myocytes to changes in patterns of neuro-
stimulation and work demand and that regulation of TRPC3
expression confers a form of cellular memory necessary for
physiologically important muscle plasticity.
1. Close, R. (1965) Nature 206, 718–719.
2. Olson, E. N. & Williams, R. S. (2000) BioEssays 22, 510–519.
3. Olson, E. N. & Williams, R. S. (2000) Cell 101, 689–692.
4. Close, R. (1965) Nature 206, 831–832.
5. Wu, H., Rothermel, B., Kanatous, S., Rosenberg, P., Naya, F. J., Shelton, J. M.,
Hutcheson, K. A., DiMaio, J. M., Olson, E. N., Bassel-Duby, R. & Williams,
R. S. (2001) EMBO J. 20, 6414–6423.
6. al-Amood, W. S., Buller, A. J. & Pope, R. (1973) Nature 244, 225–227.
7. Buller, A. J. & Pope, R. (1977) Philos. Trans. R. Soc. Lond. B Biol. Sci. 278,
295–305.
8. Chin, E. R., Olson, E. N., Richardson, J. A., Yang, Q., Humphries, C., Shelton,
J. M., Wu, H., Zhu, W., Bassel-Duby, R. & Williams, R. S. (1998) Genes Dev.
12, 2499–2509.
9. Wu, H., Naya, F. J., McKinsey, T. A., Mercer, B., Shelton, J. M., Chin, E. R.,
Simard, A. R., Michel, R. N., Bassel-Duby, R., Olson, E. N. & Williams, R. S.
(2000) EMBO J. 19, 1963–1973.
10. Liu, Y., Cseresnyes, Z., Randall, W. R. & Schneider, M. F. (2001) J. Cell Biol.
155, 27–39.
11. Kothary, R., Perry, M. D., Moran, L. A. & Rossant, J. (1987) Dev. Biol. 121,
342–348.
12. Zhou, B., Cron, R. Q., Wu, B., Genin, A., Wang, Z., Liu, S., Robson, P. &
Baldwin, H. S. (2002) J. Biol. Chem. 277, 10704–10711.
13. Kiselyov, K., Xu, X., Mozhayeva, G., Kuo, T., Pessah, I., Mignery, G., Zhu, X.,
Birnbaumer, L. & Muallem, S. (1998) Nature 396, 478–482.
14. Naya, F. J., Mercer, B., Shelton, J., Richardson, J. A., Williams, R. S. & Olson,
E. N. (2000) J. Biol. Chem. 275, 4545–4548.
15. Xu, X., Star, R. A., Tortorici, G. & Muallem, S. (1994) J. Biol. Chem. 269,
12645–12653.
16. Montell, C., Birnbaumer, L. & Flockerzi, V. (2002) Cell 108, 595–598.
17. Montell, C., Birnbaumer, L., Flockerzi, V., Bindels, R. J., Bruford, E. A.,
Caterina, M. J., Clapham, D. E., Harteneck, C., Heller, S., Julius, D., et al.
(2002) Mol. Cell 9, 229–231.
18. Vandebrouck, C., Martin, D., Colson-Van Schoor, M., Debaix, H. & Gailly, P.
(2002) J. Cell Biol. 158, 1089–1096.
19. Ma, J. & Pan, Z. (2003) Front. Biosci. 8, D242–D255.
20. Pan, Z., Yang, D., Nagaraj, R. Y., Nosek, T. A., Nishi, M., Takeshima, H.,
Cheng, H. & Ma, J. (2002) Nat. Cell. Biol. 4, 379–383.
21. Vazquez, G., Wedel, B. J., Trebak, M., Bird, G. S. & Putney, J. W., Jr. (2003)
J. Biol. Chem. 278, 21649–21654.
22. Trebak, M., Bird, G. S., McKay, R. R. & Putney, J. W., Jr. (2002) J. Biol. Chem.
277, 21617–21623.
23. Zitt, C., Obukhov, A. G., Strubing, C., Zobel, A., Kalkbrenner, F., Luckhoff,
A. & Schultz, G. (1997) J. Cell Biol. 138, 1333–1341.
24. Genazzani, A. A., Carafoli, E. & Guerini, D. (1999) Proc. Natl. Acad. Sci. USA
96, 5797–5801.
25. Graef, I. A., Mermelstein, P. G., Stankunas, K., Neilson, J. R., Deisseroth, K.,
Tsien, R. W. & Crabtree, G. R. (1999) Nature 401, 703–708.
26. Williams, R. S. & Rosenberg, P. (2002) Cold Spring Harbor Symp. Quant. Biol.
67, 339–343.
27. Bonilla, M. & Cunningham, K. W. (2002) Sci. STKE 2002, PE17.
28. Armstrong, C. M., Bezanilla, F. M. & Horowicz, P. (1972) Biochim. Biophys.
Acta 267, 605–608.
29. Lefaucheur, J. P., Pastoret, C. & Sebille, A. (1995) Anat. Rec. 242, 70–76.
30. Feske, S., Draeger, R., Peter, H. H. & Rao, A. (2000) Immunobiology 202,
134–150.
9392  www.pnas.orgcgidoi10.1073pnas.0308179101 Rosenberg et al.
